Pershing Square Lotus Award for Ovarian Cancer Research
Pershing Square Lotus Award for Ovarian Cancer Research supports investigators pursuing bold ovarian cancer studies and research in other cancers to advance discoveries that improve survival.
Browse similar grants
Funder: Pershing Square Philanthropies
Due Dates: January 4, 2027 (Applications open) | February 1, 2027, 5:00 p.m. ET (LOI deadline)
Funding Amounts: $750,000 over three years ($250,000 per year)
Summary: Supports bold, high-risk ovarian cancer research and work in other cancers with potential to improve ovarian cancer outcomes.
Key Information: Lead investigators without demonstrated ovarian cancer experience must include a collaborator with that background.
Description
The Lotus Award is offered through Pershing Square Philanthropies and administered by the Pershing Square Foundation (PSF). It brings together the foundation’s priorities in women’s health and cancer, supporting investigators working on promising ovarian cancer projects or research in other cancers that could affect ovarian cancer. The program seeks to bring new expertise into an understudied, underfunded field with limited early-detection and treatment options.
The award backs high-risk, high-reward ideas and collaboration across scientific disciplines. Supported areas may include basic research, early detection, immune-oncology, realistic disease models, novel technologies, dormant-cell research, and translational or therapeutic applications. Its goals are to empower ovarian cancer researchers to pursue their boldest ideas, attract investigators with distinctive expertise, and advance discoveries that improve survival and offer women hope.
